Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acyl-CoA reductase 2 pseudogene 1 (FAR2P1) is classified as a pseudogene, meaning it is a non-functional segment of DNA that resembles a gene but does not encode a functional protein[2][6][9][10]. FAR2P1 is related by sequence to the fatty acyl-CoA reductase 2 (FAR2) gene, which is involved in the synthesis of fatty alcohols, but FAR2P1 itself does not have a recognized biological function and there is no evidence it acts as an enzyme, receptor, or therapeutic target[2][6][9][10]. There is no current evidence linking this pseudogene to any disease role, drug interactions, or biomarker status. The gene is cataloged under the synonym LOC440905 and has limited characterization other than its classification as a pseudogene. Key points: - It is not a therapeutic target, receptor, enzyme, or other druggable entity[2][5][6][9][10]. - No known biological function, disease association, or therapeutic relevance[2][5][6][9][10]. - It is not a misspelling or an incorrect entry, but is a valid pseudogene locus[2][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acyl-CoA reductase 2 pseudogene 1 (FAR2P1).